Published in Epilepsy Behav Case Rep on November 08, 2012
A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther (1981) 69.83
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet (2005) 5.44
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA (2004) 4.85
Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation (2011) 2.36
The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol (2007) 1.97
Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia (2007) 1.74
Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial. J Pain (2009) 1.68
Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial. Epilepsia (2009) 1.58
Gender and perceived severity of cardiac disease: evidence that women are "tougher". Am J Med (2005) 1.46
Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia (2010) 1.34
Breast enlargement during chronic antidepressant therapy. J Affect Disord (1997) 1.06
The mechanisms of atrial fibrillation in hyperthyroidism. Thyroid Res (2009) 1.03
Safety and efficacy of lacosamide in the intensive care unit. Neurocrit Care (2012) 0.96
Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures. Epilepsy Behav (2010) 0.95
Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy. Epilepsia (2011) 0.94
New-onset atrial fibrillation in severe sepsis and risk of stroke and death: a critically appraised topic. Neurologist (2012) 0.89
Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety. Ther Clin Risk Manag (2009) 0.84
Atrioventricular block following lacosamide intoxication. Epilepsy Behav (2011) 0.82
Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures. Epilepsia (2012) 0.82
Clinical perspectives on lacosamide. Epilepsy Curr (2009) 0.82
Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders. CNS Drugs (2009) 0.82
Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients. Epilepsy Behav (2010) 0.82
Intravenous Lacosamide in refractory nonconvulsive status epilepticus. Seizure (2012) 0.78
Syncope in cardiac amyloidosis and chronic ischemic heart disease: A case report. Exp Clin Cardiol (2011) 0.77